BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11746264)

  • 21. The relationship between proangiogenic gene expression levels in prostate cancer and their prognostic value for clinical outcomes.
    Mori R; Dorff TB; Xiong S; Tarabolous CJ; Ye W; Groshen S; Danenberg KD; Danenberg PV; Pinski JK
    Prostate; 2010 Nov; 70(15):1692-700. PubMed ID: 20564320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TabBO: a model reflecting common molecular features of androgen-independent prostate cancer.
    Navone NM; Rodriquez-Vargas MC; Benedict WF; Troncoso P; McDonnell TJ; Zhou JH; Luthra R; Logothetis CJ
    Clin Cancer Res; 2000 Mar; 6(3):1190-7. PubMed ID: 10741751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p53 protein accumulation and gene mutation in the progression of human prostate carcinoma.
    Navone NM; Troncoso P; Pisters LL; Goodrow TL; Palmer JL; Nichols WW; von Eschenbach AC; Conti CJ
    J Natl Cancer Inst; 1993 Oct; 85(20):1657-69. PubMed ID: 7692074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p53 and p21 Expression levels predict organ preservation and survival in invasive bladder carcinoma treated with a combined-modality approach.
    Garcia del Muro X; Condom E; Vigués F; Castellsagué X; Figueras A; Muñoz J; Solá J; Soler T; Capellà G; Germà JR
    Cancer; 2004 May; 100(9):1859-67. PubMed ID: 15112266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Androgen ablation-induced programmed death of prostatic glandular cells does not involve recruitment into a defective cell cycle or p53 induction.
    Furuya Y; Lin XS; Walsh JC; Nelson WG; Isaacs JT
    Endocrinology; 1995 May; 136(5):1898-906. PubMed ID: 7720636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of p53 and p21 expression with clinical outcome in patients with carcinoma in situ of the urinary bladder.
    Shariat SF; Kim J; Raptidis G; Ayala GE; Lerner SP
    Urology; 2003 Jun; 61(6):1140-5. PubMed ID: 12809883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p53, p21(Waf1/Cip1) and cyclin D1 protein expression and prognosis in esophageal cancer.
    Kuwahara M; Hirai T; Yoshida K; Yamashita Y; Hihara J; Inoue H; Toge T
    Dis Esophagus; 1999; 12(2):116-9. PubMed ID: 10466043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival.
    Aaltomaa S; Lipponen P; Ala-Opas M; Eskelinen M; Syrjänen K; Kosma VM
    Br J Cancer; 1999 Aug; 80(12):2001-7. PubMed ID: 10471053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prognostic significance of p53, p21 (Waf1/Cip1), and cyclin D1 protein expression in esophageal cancer patients.
    Hirai T; Kuwahara M; Yoshida K; Osaki A; Toge T
    Anticancer Res; 1999; 19(5C):4587-91. PubMed ID: 10650815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of cell cycle regulatory proteins in muscle-infiltrating bladder cancer.
    Galmozzi F; Rubagotti A; Romagnoli A; Carmignani G; Perdelli L; Gatteschi B; Boccardo F
    J Cancer Res Clin Oncol; 2006 Dec; 132(12):757-64. PubMed ID: 16804724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of p21WAF1/CIP1 expression on tumor progression in bladder cancer.
    Stein JP; Ginsberg DA; Grossfeld GD; Chatterjee SJ; Esrig D; Dickinson MG; Groshen S; Taylor CR; Jones PA; Skinner DG; Cote RJ
    J Natl Cancer Inst; 1998 Jul; 90(14):1072-9. PubMed ID: 9672255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Value of expression of p21WAF1/CIP1 as a prognostic factor in advanced middle and lower rectal cancer patients treated with preoperative radio-chemotherapy.
    Sogawa N; Takiguchi N; Koda K; Oda K; Satomi D; Kato K; Ishikura H; Miyazaki M
    Int J Oncol; 2002 Oct; 21(4):787-93. PubMed ID: 12239617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. WAF1/p21 protein expression is an independent prognostic indicator in superficial and invasive bladder cancer.
    Korkolopoulou P; Konstantinidou AE; Thomas-Tsagli E; Christodoulou P; Kapralos P; Davaris P
    Appl Immunohistochem Mol Morphol; 2000 Dec; 8(4):285-92. PubMed ID: 11127920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p53, p21 and p27 protein expression in head and neck cancer and their prognostic value.
    Kapranos N; Stathopoulos GP; Manolopoulos L; Kokka E; Papadimitriou C; Bibas A; Yiotakis J; Adamopoulos G
    Anticancer Res; 2001; 21(1B):521-8. PubMed ID: 11299798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer.
    Shariat SF; Tokunaga H; Zhou J; Kim J; Ayala GE; Benedict WF; Lerner SP
    J Clin Oncol; 2004 Mar; 22(6):1014-24. PubMed ID: 14981102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of retinoblastoma gene product and p21 (WAF1/Cip 1) protein in gliomas: correlations with proliferation markers, p53 expression and survival.
    Korkolopoulou P; Kouzelis K; Christodoulou P; Papanikolaou A; Thomas-Tsagli E
    Acta Neuropathol; 1998 Jun; 95(6):617-24. PubMed ID: 9650754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical relevance of expression of the CIP/KIP cell-cycle inhibitors p21 and p27 in laryngeal cancer.
    Pruneri G; Pignataro L; Carboni N; Buffa R; Di Finizio D; Cesana BM; Neri A
    J Clin Oncol; 1999 Oct; 17(10):3150-9. PubMed ID: 10506612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p53 status and prognosis of locally advanced prostatic adenocarcinoma: a study based on RTOG 8610.
    Grignon DJ; Caplan R; Sarkar FH; Lawton CA; Hammond EH; Pilepich MV; Forman JD; Mesic J; Fu KK; Abrams RA; Pajak TF; Shipley WU; Cox JD
    J Natl Cancer Inst; 1997 Jan; 89(2):158-65. PubMed ID: 8998185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical expression of the p53, mdm2, p21/Waf-1, Rb, p16, Ki67, cyclin D1, cyclin A and cyclin B1 proteins and apoptotic index in T-cell lymphomas.
    Kanavaros P; Bai M; Stefanaki K; Poussias G; Rontogianni D; Zioga E; Gorgoulis V; Agnantis NJ
    Histol Histopathol; 2001 Apr; 16(2):377-86. PubMed ID: 11332692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclin D1, p53, and p21Waf1/Cip1 expression is predictive of poor clinical outcome in serous epithelial ovarian cancer.
    Bali A; O'Brien PM; Edwards LS; Sutherland RL; Hacker NF; Henshall SM
    Clin Cancer Res; 2004 Aug; 10(15):5168-77. PubMed ID: 15297421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.